Characterizing hepatitis C virus epidemiology in Egypt: Systematic reviews, meta-analyses, and meta-regressions

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Kouyoumjian, Silva P ^a   Chemaitelly, Hiam ^a   Abu Raddad, Laith J ^a,b  

^a Department of Obstetrics Gynecology   (Qatar)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION; DISEASE TRANSMISSION; EGYPT; GENETICS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMAN; IATROGENIC DISEASE; INCIDENCE; ISOLATION AND PURIFICATION; META ANALYSIS; MOLECULAR EPIDEMIOLOGY; PREVALENCE;

DISEASE TRANSMISSION, INFECTIOUS; EGYPT; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; IATROGENIC DISEASE; INCIDENCE; MOLECULAR EPIDEMIOLOGY; PREVALENCE;

EID: 85041140244     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-17936-4     Document Type: Review

References (168)

1. Stanaway, J. D. et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet, https://doi. org/10. 1016/S0140-6736(16)30579-7 (2016).
2. Mohd Hanafiah, K., Groeger, J., Flaxman, A. D. & Wiersma, S. T. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57, 1333-1342, https://doi. org/10. 1002/hep. 26141 (2013).
3. Lavanchy, D. Evolving epidemiology of hepatitis Cvirus. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 17, 107-115, https://doi. org/10. 1111/j. 1469-0691. 2010. 03432. x (2011).
4. World Health Organization. Hepatitis C: fact sheet. http://www. who. int/mediacentre/factsheets/fs164/en/. Updated April 2017. Accessed on April 24, 2017.
5. Ayoub, H. H. & Abu-Raddad, L. J. Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention. Journal of viral hepatitis 31, 12671 (2016).
6. Centers for Disease Control and Prevention. Hepatitis C. http://wwwnc. cdc. gov/travel/yellowbook/2014/chapter-3-infectiousdiseases-related-to-travel/hepatitis-c. Published July 10, 2015. Accessed on April 24, 2017.
7. A SPECIAL MEETING REVIEW EDITION: Advances in the Treatment of Hepatitis C Virus Infection From EASL 2015: The 50th Annual Meeting of the European Association for the Study of the Liver April 22-26, 2015 Vienna, AustriaSpecial Reporting on:Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients With Advanced Cirrhosis or Posttransplant Recurrence: Phase 3 ALLY-1 Study Efficacy and Safety of Grazoprevir and Elbasvir in Hepatitis C Genotype 1-Infected Patients With Child-Pugh Class B Cirrhosis (C-SALT Part A) Ledipasvir/Sofosbuvir With Ribavirin Is Safe and Efficacious in Decompensated and Post Liver Transplantation Patients With HCV Infection: Preliminary Results of the Prospective SOLAR 2 Trial Retreatment of Patients Who Failed 8 or 12 Weeks of Ledipasvir/Sofosbuvir-Based Regimens With Ledipasvir/Sofosbuvir for 24 Weeks Sofosbuvir + Peginterferon/Ribavirin for 12 Weeks Vs Sofosbuvir + Ribavirin for 16 or 24 Weeks in Genotype 3 HCV Infected Patients and Treatment-Experienced Cirrhotic Patients With Genotype 2 HCV: The BOSON Study Safety and Efficacy of the Combination Daclatasvir-Sofosbuvir in HCV Genotype 1-Mono-Infected Patients From the French Observational Cohort ANRS CO22 HEPATHER C-SWIFT: Grazoprevir/Elbasvir+Sofosbuvir in Cirrhotic and Noncirrhotic, Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection for Durations of 4, 6 or 8 Weeks and Genotype 3 Infection for Durations of 8 or 12 WeeksPLUS Meeting Abstract Summaries With Expert Commentary by: S L. Flamm, MD Chief, Liver Transplantation ProgramProfessor of Medicine and SurgeryNorthwestern University Feinberg School of MedicineChicago, Illinois. Gastroenterol Hepatol (N Y) 11, 1-23 (2015).
8. World Health Organization. Global Health Sector Strategy on Viral Hepatitis, 2016-2021, (Geneva, Switzerland: World Health Organization, 2015).
9. World Health Organization. Combating Hepatitis B and C to Reach Elimination by 2030. (Geneva, Switzerland: World Health Organization, 2016).
10. United Nations General Assembly. Transforming our world: the 2030 Agenda for Sustainable Development (2015).
11. El-Zanaty, F. & Way, A. Egypt Demographic and Health Survey 2008., (Ministry of Health, El-Zanaty and Associates, and Macro International., Cairo, Egypt, 2009).
12. Ministry of Health and Population [Egypt], El-Zanaty and Associates [Egypt] & and ICF International. Egypt Health Issues Survey 2015. (Cairo, Egypt and Rockville, Maryland, USA: Ministry of Health and Population and ICF International, 2015).
13. Cornberg, M. et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver international: official journal of the International Association for the Study of the Liver 31(Suppl 2), 30-60, https://doi. org/10. 1111/j. 1478-3231. 2011. 02539. x (2011).
14. Gamal, E. Situation of HCV in Egypt Towards an End to HCV Epidemic, http://www. liver-eg. org/assets/esmatt-hepatitis-c-situationin-egypt. pdf (2014).
15. Egyptian Economic and Social Justice Unit. HCV Treatment in Egypt. Why cost remains a challenge? https://www. eipr. org/sites/ default/files/pressreleases/pdf/hcv-treatment-in-egypt. pdf. Published November 2014. Accessed on April 24, 2017.
16. Egyptian Ministry of Health and Population. Plan of Action for the Prevention, Care & Treatment of Viral Hepatitis, Egypt 2014-2018. http://www. emro. who. int/images/stories/egypt/VH-Plan-of-Action-FINAL-PRINT1. pdf. Published 2014. Accessed on April 24, 2017.
17. Kim, D. D. et al. Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence. Global public health 10, 296-317, https://doi. org/10. 1080/17441692. 2014. 984742 (2015).
18. McNeil Jr., D. G. Curing Hepatitis C, in an Experiment the Size of Egypt. The New York Times. December 16, (2015).
19. Miller, F. D. & Abu-Raddad, L. J. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proceedings of the National Academy of Sciences of the United States of America 107, 14757-14762, https://doi. org/10. 1073/pnas. 1008877107 (2010).
20. Cuadros, D. F., Branscum, A. J., Miller, F. D. & Abu-Raddad, L. J. Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications. Hepatology 60, 1150-1159, https://doi. org/10. 1002/hep. 27248 (2014).
21. Mohamoud, Y. A., Mumtaz, G. R., Riome, S., Miller, D. & Abu-Raddad, L. J. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC infectious diseases 13, 288, https://doi. org/10. 1186/1471-2334-13-288 (2013).
22. The epidemiology of hepatitis C virus in the World Health Organization Eastern Mediterranean Region: Implications for strategic action (in press).
23. Chaabna, K., Mohamoud, Y. A., Chemaitelly, H., Mumtaz, G. R. & Abu-Raddad, L. J. Protocol for a systematic review and metaanalysis of hepatitis C virus (HCV) prevalence and incidence in The Horn of Africa sub-region of the Middle East and North Africa. PROSPERO 2014: CRD42014010318. http://www. crd. york. ac. uk/PROSPERO/display-record. asp?ID=CRD42014010318. Published 2014. Accessed on April 24, 2017.
24. Chaabna, K., Mohamoud, Y. A., Chemaitelly, H., Mumtaz, G. R. & Abu-Raddad, L. J. Protocol for a systematic review and metaanalysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa. Systematic reviews 3, 146, https://doi. org/10. 1186/2046-4053-3-146 (2014).
25. Mohamoud, Y. A., Riome, S. & Abu-Raddad, L. J. Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases, https://doi. org/10. 1016/j. ijid. 2016. 03. 012 (2016).
26. Fadlalla, F. A., Mohamoud, Y. A., Mumtaz, G. R. & Abu-Raddad, L. J. The epidemiology of hepatitis C virus in the maghreb region: systematic review and meta-analyses. PloS one 10, e0121873, https://doi. org/10. 1371/journal. pone. 0121873 (2015).
27. Chaabna, K., Kouyoumjian, S. P. & Abu-Raddad, L. J. Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis. PloS one 11, e0149966, https://doi. org/10. 1371/journal. pone. 0149966 (2016).
28. Chemaitelly, H., Mahmud, S., Rahmani, A. M. & Abu-Raddad, L. J. The epidemiology of hepatitis C virus in Afghanistan: Systematic review and meta-analysis. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases, https://doi. org/10. 1016/j. ijid. 2015. 09. 011 (2015).
29. Mahmud, S., Akbarzadeh, V. & Abu-Raddad, L. J. The epidemiology of hepatitis C virus in Iran: Systematic review and metaanalyses. Scientific Reports, 8, 150, https://doi. org/10. 1038/s41598-017-18296-9 (2018).
30. Chemaitelly, H., Chaabna, K. & Abu-Raddad, L. J. The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis. PloS one 10, e0135281, https://doi. org/10. 1371/journal. pone. 0135281 (2015).
31. Higgins, J. P. & Green, S. Cochrane handbook for systematic reviews of interventions. Vol. 5 (Wiley Online Library, 2008).
32. Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G. & Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine 6, e1000097, https://doi. org/10. 1371/journal. pmed. 1000097 (2009).
33. Bouvard, V. et al. A review of human carcinogens-Part B: biological agents. The Lancet. Oncology 10, 321-322 (2009).
34. Chaabna, K. et al. Geographical patterns of Kaposi's sarcoma, nonHodgkin lymphomas, and cervical cancer associated with HIV infection in five African populations. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP) 21, 1-9, https://doi. org/10. 1097/CEJ. 0b013e32834a802a (2012).
35. The Cochrane collaboration. Cochrane handbook for systematic reviews of interventions. (Wiley-Blackweill, 2008).
36. Shannon, C. E. The mathematical theory of communication. 1963. M. D. computing: computers in medical practice 14, 306-317 (1997).
37. Messina, J. P. et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61, 77-87, https://doi. org/10. 1002/ hep. 27259 (2015).
38. Freeman, M. F. & Tukey, J. W. Transformations related to the angular and the square root. The Annals of Mathematical Statistics, 21, 607-611 (1950).
39. Borenstein, M. Introduction to meta-analysis. (John Wiley & Sons, 2009).
40. Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. Bmj 327, 557-560, https:// doi. org/10. 1136/bmj. 327. 7414. 557 (2003).
41. R Core Team. R 3. 2. 2: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www. R-project. org/. (2017).
42. Schwarzer, G. meta: An R package for meta-analysis. R News 7, 40-45 (2007).
43. StataCorp. Stata Statistical Software: Release 12. College Station, TX: StatCorp LP (2011).
44. Harbord, R. & Higgins, J. Meta-regression in Stata. The Stata Journal 8, 493-519 (2008).
45. Abu-Raddad L et al. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: Time for strategic action. (The World Bank Press, 2010).
46. Abu-Raddad, L. J. et al. Epidemiology of HIV infection in the Middle East and North Africa. AIDS (London, England) 24(Suppl 2), S5-23, https://doi. org/10. 1097/01. aids. 0000386729. 56683. 33 (2010).
47. Hagag, S. A., Koura, S. K. & Abdel Hameed, M. F. Seroprevalence of hepatitis C virus infection among the volunteer blood donors in Zagazig. Zagazig University Medical Journal 4, 199-209 (1998).
48. Mohamed, M. K. et al. Intrafamilial transmission of hepatitis C in Egypt. Hepatology 42, 683-687, https://doi. org/10. 1002/ hep. 20811 (2005).
49. Mostafa, A. et al. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver international: official journal of the International Association for the Study of the Liver 30, 560-566, https://doi. org/10. 1111/j. 1478-3231. 2009. 02204. x (2010).
50. Saleh, D. A. et al. Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt. Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 921-928, https://doi. org/10. 1016/j. trstmh. 2008. 04. 011 (2008).
51. Mikhail, N. N. et al. Prospective study of cross-infection from upper-GI endoscopy in a hepatitis C-prevalent population. Gastrointestinal endoscopy 65, 584-588, https://doi. org/10. 1016/j. gie. 2006. 07. 033 (2007).
52. Munier, A. et al. Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, Egypt. PloS one 8, e57835, https://doi. org/10. 1371/journal. pone. 0057835 (2013).
53. Abdel-Wahab, M. et al. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma. Hepato-gastroenterology 60, 1847-1853 (2013).
54. Okasha, O. et al. Hepatitis C virus infection and risk factors in health-care workers at Ain Shams University Hospitals, Cairo, Egypt. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq almutawassit 21, 199-212 (2015).
55. Saleh, D. A. et al. Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children. Transactions of the Royal Society of Tropical Medicine and Hygiene 104, 357-363, https://doi. org/10. 1016/j. trstmh. 2010. 01. 009 (2010).
56. Youssef Hassan, M. & Samra, A. M. M. HCV sero-conversion in HCV negative recipients of allogenic HSCT. Vox Sanguinis 105, 179, https://doi. org/10. 1111/vox. 12048 (2013).
57. AbdulQawi, K. et al. Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants. Croatian medical journal 51, 219-228 (2010).
58. Kumar, R. M., Frossad, P. M. & Hughes, P. F. Seroprevalence and mother-to-infant transmission of hepatitis C in asymptomatic Egyptian women. European journal of obstetrics, gynecology, and reproductive biology 75, 177-182 (1997).
59. Kassem, A. S., el-Nawawy, A. A., Massoud, M. N., el-Nazar, S. Y. & Sobhi, E. M. Prevalence of hepatitis C virus (HCV) infection and its vertical transmission in Egyptian pregnant women and their newborns. Journal of tropical pediatrics 46, 231-233 (2000).
60. Shebl, F. M. et al. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. Journal of medical virology 81, 1024-1031, https://doi. org/10. 1002/jmv. 21480 (2009).
61. Abo Elmagd, E. K., Abdel-Wahab, K. S., Alrasheedy, Z. E. & Khalifa, A. S. An Egyptian study of mother to child transmission of hepatitis C virus. International Journal of Virology 7, 100-108, https://doi. org/10. 3923/ijv. 2011. 100. 108 (2011).
62. El Sayed Zaki, M., El Aal, A. A., Badawy, A., El-Deeb, D. R. & El-Kheir, N. Y. Clinicolaboratory study of mother-to-neonate transmission of hepatitis E virus in Egypt. American journal of clinical pathology 140, 721-726, https://doi. org/10. 1309/ ajcpt55tdmjnpllv (2013).
63. Abdelwahab, M. S., El-Raziky, M. S., Kaddah, N. A. & Abou-Elew, H. H. Prevalence of hepatitis C virus infection and human immunodeficiency virus in a cohort of Egyptian hemophiliac children. Annals of Saudi medicine 32, 200-202 (2012).
64. el-Ghazzawi, E. et al. Intravenous drug addicts: a high risk group for infection with human immunodeficiency virus, hepatitis viruses, cytomegalo virus and bacterial infections in Alexandria Egypt. The Journal of the Egyptian Public Health Association 70, 127-150 (1995).
65. Mohamed, H. I. et al. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases. Journal of infection and public health 6, 186-195, https://doi. org/10. 1016/j. jiph. 2012. 12. 003 (2013).
66. Quinti, I. et al. Seroprevalence of HIV and HCV infections in Alexandria, Egypt. Zentralblatt fur Bakteriologie: international journal of medical microbiology 283, 239-244 (1995).
67. Ali, F., Abdel-Aziz, A., Helmy, M. F., Abdel-Mobdy, A. & Darwish, M. Prevalence of certain sexually transmitted viruses in Egypt. The Journal of the Egyptian Public Health Association 73, 181-192 (1998).
68. Hassan, N. F. Prevalence of hepatitis C antibodies in patient groups in Egypt. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 638 (1993).
69. Tantawy, A. A. G., Sallam, T. H., Ibrahim, D. M., Sallam, M. T. & Ragab, I. A. Pathogenesis and prognosis of neutropenia in infants and children admitted in a university children hospital in Egypt. Pediatric Hematology and Oncology 30, 51-59, https://doi. org/10. 3109/08880018. 2012. 743199 (2013).
70. Khalifa, A. S. et al. Prevalence of hepatitis C viral antibody in transfused and nontransfused Egyptian children. The American journal of tropical medicine and hygiene 49, 316-321 (1993).
71. Attallah, A. M. & Ibrahim, G. G. Immunodetection of a hepatitis C virus (HCV) antigen and Thl/Th2 cytokines in cerebrospinal fluid of meningitis patients. Journal of immunoassay & immunochemistry 25, 313-320 (2004).
72. Shalaby, S. et al. Hepatitis B and C viral infection: prevalence, knowledge, attitude and practice among barbers and clients in Gharbia governorate, Egypt. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 16, 10-17 (2010).
73. Derbala, M. et al. Epidemiology of HCV in Egypt according to age: Parenteral antischistosomal therapy: the accused innocent, http://0-ovidsp. ovid. com. elibrary. qatar-weill. cornell. edu/ovidweb. cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=71384393 (2014).
74. Edris, A. et al. Seroprevalence and risk factors for hepatitis B and C virus infection in Damietta Governorate, Egypt. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 20, 605-613 (2014).
75. Zuure, F. R. et al. Screening for hepatitis B and C in first-generation Egyptian migrants living in the Netherlands. Liver international: official journal of the International Association for the Study of the Liver 33, 727-738, https://doi. org/10. 1111/liv. 12131 (2013).
76. Mohamed, M. K. et al. HCV-related morbidity in a rural community of Egypt. Journal of medical virology 78, 1185-1189, https:// doi. org/10. 1002/jmv. 20679 (2006).
77. Stoszek, S. K. et al. Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 102-107, https://doi. org/10. 1016/j. trstmh. 2005. 05. 021 (2006).
78. Arafa, N. et al. Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol 43, 418-424, https://doi. org/10. 1016/j. jhep. 2005. 03. 021 (2005).
79. el-Sadawy, M. et al. Hepatitis C virus infection at Sharkia Governorate, Egypt: seroprevalence and associated risk factors. Journal of the Egyptian Society of Parasitology 34, 367-384 (2004).
80. Strickland, G. T. et al. Role of hepatitis C infection in chronic liver disease in Egypt. The American journal of tropical medicine and hygiene 67, 436-442 (2002).
81. Abdel-Aziz, F. et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 32, 111-115, https://doi. org/10. 1053/jhep. 2000. 8438 (2000).
82. Nafeh, M. A. et al. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. The American journal of tropical medicine and hygiene 63, 236-241 (2000).
83. Angelico, M. et al. Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol 26, (236-243 (1997).
84. el-Sayed, H. F., Abaza, S. M., Mehanna, S. & Winch, P. J. The prevalence of hepatitis B and C infections among immigrants to a newly reclaimed area endemic for Schistosoma mansoni in Sinai, Egypt. Acta tropica 68, 229-237 (1997).
85. El-Zayadi, A. et al. Evaluation of risk factors for intrafamilial transmission of HCV infection in Egypt. The Journal of the Egyptian Public Health Association 72, 33-51 (1997).
86. Mohamed, M. K. et al. Study of the risk factors for viral hepatitis C infection among Egyptians applying for work abroad. The Journal of the Egyptian Public Health Association 71, 113-147 (1996).
87. Bassily, S. International Conference on Schistosomiasis. The Srp 1993-Le Caire, 14-18 Fevrier 1993. Hepatite B, Hepatite C Et Bilharziose. Medecine et Chirurgie Digestives 22, 441-442 (1993).
88. Zakaria, S. et al. A community-based study of viral hepatitis infection in Giza Governorate, Egypt: Seroprevalence, risk factors and associated morbidity. The Medical Journal of Cairo University 73, 899 (2005).
89. Zahran, A. M. Prevalence of Seroconversion of Hepatitis C Virus among Hemodialysis Patients in Menoufia Governorate, Egypt. Arab journal of nephrology and transplantation 7, 133-135 (2014).
90. Ismail, Z. A., Soliman, H. A. & Zahran, A. M. & Kamal El Din, A. M. Prevalence of hepatitis C virus antibodies in hemodialysis patients. The Medical Journal of Cairo University 62, 283-291 (1994).
91. Huraib, S. et al. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: a need for new dialysis strategies. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association 10, 470-474 (1995).
92. Soliman, A. R., Momtaz Abd Elaziz, M. & El Lawindi, M. I. Evaluation of an isolation program of hepatitis C virus infected hemodialysis patients in some hemodialysis centers in egypt. ISRN nephrology 2013, 395467, https://doi. org/10. 5402/2013/395467 (2013).
93. Sabry, A. Proteinuria among renal transplant patients and its relation to hepatitis C virus and graft outcome: a single center experience. Experimental and clinical transplantation: official journal of the Middle East Society for Organ Transplantation 8, 91-97 (2010).
94. Gohar, S. A., Khalil, R. Y., Elaish, N. M., Khedr, E. M. & Ahmed, M. S. Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients. The Journal of the Egyptian Public Health Association 70, 465-484 (1995).
95. Abdel-Wahab, M. F. et al. High seroprevalence of hepatitis C infection among risk groups in Egypt. The American journal of tropical medicine and hygiene 51, 563-567 (1994).
96. Goher, S. A., Abdel-Ghany, M. M., Shaarawy, A.-B. & Sobhy, S. A. Dialyzer reuse and hepatitis C virus in hemodialysis population in Egypt. Scientific Medical Journal 10, 43-54 (1998).
97. Saddik, Y. & El Azoni, M. Hepatitis Cvirus [HCV] antibodies in patients with chronic renal failure and treated with regular hemodialysis and those treated with renal transplantation. Scientific Medical Journal 9, 79-99 (1997).
98. Adly, A. A. & Ebeid, F. S. Cultural preferences and limited public resources influence the spectrum of thalassemia in Egypt. Journal of pediatric hematology/oncology 37, 281-284, https://doi. org/10. 1097/mph. 0000000000000327 (2015).
99. Salama, K. M. et al. Liver enzymes in children with beta-Thalassemia major: Correlation with iron overload and viral hepatitis. Macedonian Journal of Medical Sciences 3, 287-292, https://doi. org/10. 3889/oamjms. 2015. 059 (2015).
100. Mansour, A. K. et al. Prevalence of HBV and HCV infection among multi-transfused Egyptian thalassemic patients. Hematology/ oncology and stem cell therapy 5, 54-59, https://doi. org/10. 5144/1658-3876. 2012. 54 (2012).
101. Awadalla, H. I., Ragab, M. H., Nassar, N. A. & Osman, M. A. Risk factors of hepatitis C infection among Egyptian blood donors. Central European journal of public health 19, 217-221 (2011).
102. Barakat, S. H. & El-Bashir, N. Hepatitis C virus infection among healthy Egyptian children: prevalence and risk factors. Journal of viral hepatitis 18, 779-784, https://doi. org/10. 1111/j. 1365-2893. 2010. 01381. x (2011).
103. Kalil, K. A., Farghally, H. S., Hassanein, K. M., Abd-Elsayed, A. A. & Hassanein, F. E. Hepatitis C virus infection among paediatric patients attending University of AssiutHospital, Egypt. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 16, 356-361 (2010).
104. Talaat, M. et al. Sentinel surveillance for patients with acute hepatitis in Egypt, 2001-04. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 16, 134-140 (2010).
105. Sharaf-Eldeen, S., Salama, K., Eldemerdash, S., Hassan, H. M. S. & Semesem, M. Hepatitis B and C Viruses in Egyptian children with malignancy. Journal of Medical Sciences 7, 1003-1008 (2007).
106. Farghaly, A. G., Mansour, G. A., Mahdy, N. H. & Yousri, A. Hepatitis B and C virus infections among patients with gingivitis and adult periodontitis: seroprevalence and public health importance. The Journal of the Egyptian Public Health Association 73, 707-735 (1998).
107. Darwish, N. M., Abbas, M. O., Hady, S. I. & Mohammed, T. A. Study of the high prevalence of HCV in Egypt. The Journal of the Egyptian Public Health Association 70, 397-414 (1995).
108. El-Shanshory, M. R., Kabbash, I. A., Soliman, H. H., Nagy, H. M. & Abdou, S. H. Prevalence of hepatitis C infection among children with beta-thalassaemia major in Mid Delta, Egypt: a single centre study. Transactions of the Royal Society of Tropical Medicine and Hygiene 107, 224-228, https://doi. org/10. 1093/trstmh/trs024 (2013).
109. el-Sayed, N. M. et al. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt. The American journal of tropical medicine and hygiene 55, 179-184 (1996).
110. El-bendary, M. et al. Epidemiological aspects of intrafamilial spread of HCV infection in Egyptian population a pilot study. Hepatology International 1, S65, https://doi. org/10. 1007/s12072-015-9609-1 (2015).
111. El-Kamary, S. S. et al. Reliability of risk-based screening for hepatitis C virus infection among pregnant women in Egypt. The Journal of infection 70, 512-519, https://doi. org/10. 1016/j. jinf. 2015. 01. 009 (2015).
112. Guerra, J., Garenne, M., Mohamed, M. K. & Fontanet, A. HCV burden of infection in Egypt: results from a nationwide survey. Journal of viral hepatitis 19, 560-567, https://doi. org/10. 1111/j. 1365-2893. 2011. 01576. x (2012).
113. Eassa, S., Eissa, M., Sharaf, S. M., Ibrahim, M. H. & Hassanein, O. M. Prevalence of hepatitis C virus infection and evaluation of a health education program in el-ghar village in zagazig, egypt. The Journal of the Egyptian Public Health Association 82, 379-404 (2007).
114. El Sharkawi, F. Z., Chudy, M., Hanschmann, K. M., Kress, J. & Nubling, C. M. Consistency of quantitation of HCV genotype 4 from egypt across three HCV-RNA amplification assays. Journal of medical virology 80, 2086-2091, https://doi. org/10. 1002/jmv. 21325 (2008).
115. McOmish, F. et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. Journal of clinical microbiology 32, 884-892 (1994).
116. Pohjanpelto, P. Risk factors connected with hepatitis C infections in Finland. Scandinavian journal of infectious diseases 24, 251-252 (1992).
117. Tanaka, Y. et al. Exponential spread of hepatitis C virus genotype 4a in Egypt. Journal of molecular evolution 58, 191-195, https:// doi. org/10. 1007/s00239-003-2541-3 (2004).
118. Agha, S., Sherif, L. S., Allam, M. A. & Fawzy, M. Transplacental transmission of hepatitis C virus in HIV-negative mothers. Research in virology 149, 229-234 (1998).
119. Fakeeh, M. & Zaki, A. M. Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia. The American journal of tropical medicine and hygiene 61, 889-892 (1999).
120. Derbala, M. et al. Reexamination of the relationship between the prevalence of hepatitis C virus and parenteral antischistosomal therapy among Egyptians resident in Qatar. Clinical and experimental gastroenterology 7, 427-433, https://doi. org/10. 2147/ceg. s65369 (2014).
121. Said, F. et al. Intrafamilial transmission of hepatitis C infection in Egyptian multitransfused thalassemia patients. Journal of tropical pediatrics 59, 309-313, https://doi. org/10. 1093/tropej/fmt017 (2013).
122. Elsawy, E. M. et al. Serotyping of hepatitis C virus in hemodialysis patients: comparison with a standardized genotyping assay. Diagnostic microbiology and infectious disease 51, 91-94, https://doi. org/10. 1016/j. diagmicrobio. 2004. 09. 010 (2005).
123. Abdelwahab, S. et al. Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre. Transactions of the Royal Society of Tropical Medicine and Hygiene 106, 98-103, https://doi. org/10. 1016/j. trstmh. 2011. 10. 003 (2012).
124. Allam, W. R. et al. Schistosomiasis does not affect the outcome of HCV infection in genotype 4-infected patients. The American journal of tropical medicine and hygiene 90, 823-829, https://doi. org/10. 4269/ajtmh. 13-0703 (2014).
125. Halim, A. B., Garry, R. F., Dash, S. & Gerber, M. A. Effect of schistosomiasis and hepatitis on liver disease. The American journal of tropical medicine and hygiene 60, 915-920 (1999).
126. Chehadeh, W. et al. Hepatitis C virus infection in a population with high incidence of type 2 diabetes: impact on diabetes complications. Journal of infection and public health 4, 200-206, https://doi. org/10. 1016/j. jiph. 2011. 05. 004 (2011).
127. Yates, S. C. et al. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level. The American journal of tropical medicine and hygiene 60, 714-720 (1999).
128. El-Zayadi, A., Simmonds, P., Dabbous, H. & Selim, O. Hepatitis C virus genotypes among HCV-chronic liver disease patients in Egypt: a leading trial. The Journal of the Egyptian Public Health Association 69, 327-334 (1994).
129. Gad, A. et al. Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect. Journal of gastroenterology 36, 753-758 (2001).
130. Youssef, A., Yano, Y., El-Sayed Zaki, M., Utsumi, T. & Hayashi, Y. Characteristics of hepatitis viruses among Egyptian children with acute hepatitis. International journal of oncology 42, 1459-1465, https://doi. org/10. 3892/ijo. 2013. 1822 (2013).
131. El Gaafary, M. M. et al. Surveillance of acute hepatitis C in Cairo, Egypt. Journal of medical virology 76, 520-525, https://doi. org/10. 1002/jmv. 20392 (2005).
132. Quinti, I. et al. HCV infection in Egyptian patients with acute hepatitis. Digestive diseases and sciences 42, 2017-2023 (1997).
133. Zekri, A. R. N. et al. Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma. J. Med. Microbiol. 49, 89-95 (2000).
134. Sabry, A. A. et al. A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association 17, 239-245 (2002).
135. Zekri, A. R. et al. TRUGENE sequencing versus INNO-LiPA for sub-genotyping of HCV genotype-4. Journal of medical virology 75, 412-420, https://doi. org/10. 1002/jmv. 20293 (2005).
136. Youssef, S. S., Nasr, A. S., El Zanaty, T., El Rawi, R. S. & Mattar, M. M. Prevalence of occult hepatitis C virus in egyptian patients with chronic lymphoproliferative disorders. Hepatitis research and treatment 2012, 429784, https://doi. org/10. 1155/2012/429784 (2012).
137. Zekri, A. R. et al. Hepatitis C virus genotyping versus serotyping in Egyptian patients. Infection 29, 24-26 (2001).
138. Blanton, R. E. et al. Population-based differences in Schistosoma mansoni-and hepatitis C-induced disease. The Journal of infectious diseases 185, 1644-1649, https://doi. org/10. 1086/340574 (2002).
139. Youssef, A. et al. Molecular epidemiological study of hepatitis viruses in Ismailia, Egypt. Intervirology 52, 123-131, https://doi. org/10. 1159/000219385 (2009).
140. Abdel-Hamid, M. et al. Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. The Journal of general virology 88, 1526-1531, https://doi. org/10. 1099/vir. 0. 82626-0 (2007).
141. Al-Knawy, B. et al. Distribution of hepatitis C genotype and co-infection rate with hepatitis G in Saudi Arabia. Hepatology research: the official journal of the Japan Society of Hepatology 24, 95 (2002).
142. Ryu, S. H. et al. Lack of association between genotypes and subtypes of HCV and occurrence of hepatocellular carcinoma in Egypt. Journal of medical virology 81, 844-847, https://doi. org/10. 1002/jmv. 21451 (2009).
143. Said, Z. N. et al. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies. Liver international: official journal of the International Association for the Study of the Liver 29, 518-524, https://doi. org/10. 1111/j. 1478-3231. 2009. 01975. x (2009).
144. Cowgill, K. D. et al. Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt. International journal of epidemiology 33, 1034-1039, https://doi. org/10. 1093/ije/dyh183 (2004).
145. Gower, E., Estes, C., Blach, S., Razavi-Shearer, K. & Razavi, H. Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal of hepatology 61, S45-S57 (2014).
146. Benova, L., Awad, S. F., Miller, F. D. & Abu-Raddad, L. J. Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt. Hepatology 61, 834-842, https://doi. org/10. 1002/hep. 27596 (2015).
147. Kandeel, A. et al. The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment. Liver international: official journal of the International Association for the Study of the Liver 37, 45-53, https://doi. org/10. 1111/liv. 13186 (2017).
148. Breban, R. et al. Towards realistic estimates of HCV incidence in Egypt. Journal of viral hepatitis 20, 294-296, https://doi. org/10. 1111/j. 1365-2893. 2012. 01650. x (2013).
149. Frank, C. et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355, 887-891 (2000).
150. Razavi, H., Hindman, S., Gower, E. & Estes, C. in 64th Annual Meeting of the American Association for the Study of Liver Diseases: the Liver Meeting 2013 Vol. 58, 1288A (Hepatology, Washington DC, USA, 2013).
151. Pybus, O. G., Drummond, A. J., Nakano, T., Robertson, B. H. & Rambaut, A. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Molecular biology and evolution 20, 381-387 (2003).
152. Ray, S. C., Arthur, R. R., Carella, A., Bukh, J. & Thomas, D. L. Genetic epidemiology of hepatitis C virus throughout egypt. The Journal of infectious diseases 182, 698-707, https://doi. org/10. 1086/315786 (2000).
153. Centers for Disease Control and Prevention. Continuous National Health and Nutrition Examination Survey (NHANES) Hepatitis C virus Laboratory Data. (Centers for Disease Control and Prevention, Atlanta, USA, 1999-2012). http://wwwn. cdc. gov/nchs/ nhanes/search/datapage. aspx?Component=Laboratory. Date Accessed: August 30, 2017.
154. Grebely, J. et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology 59, 109-120 (2014).
155. Hajarizadeh, B., Grebely, J. & Dore, G. J. Epidemiology and natural history of HCV infection. Nature reviews. Gastroenterology & hepatology 10, 553-562, https://doi. org/10. 1038/nrgastro. 2013. 107 (2013).
156. Ray, S. C. et al. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol 73, 2938-2946 (1999).
157. Li, K. & Lemon, S. M. Innate immune responses in hepatitis C virus infection. Semin Immunopathol 35, 53-72, https://doi. org/10. 1007/s00281-012-0332-x (2013).
158. Lemon, S. M. Induction and evasion of innate antiviral responses by hepatitis C virus. J Biol Chem 285, 22741-22747, https://doi. org/10. 1074/jbc. R109. 099556 (2010).
159. Takaki, A. et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a singlesource outbreak of hepatitis C. Nat Med 6, 578-582, https://doi. org/10. 1038/75063 (2000).
160. Micallef, J., Kaldor, J. & Dore, G. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. Journal of viral hepatitis 13, 34-41 (2006).
161. Page, K. et al. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis 200, 1216-1226, https://doi. org/10. 1086/605947 (2009).
162. Mumtaz, G. R. et al. HIV among People Who Inject Drugs in the Middle East and North Africa: Systematic Review and Data Synthesis. Plos Medicine 11, ARTN e1001663, https://doi. org/10. 1371/journal. pmed. 1001663 (2014).
163. Mumtaz, G. R., Weiss, H. A. & Abu-Raddad, L. J. Hepatitis C virus and HIV infections among people who inject drugs in the Middle East and North Africa: a neglected public health burden? J Int AIDS Soc 18, 20582, https://doi. org/10. 7448/IAS. 18. 1. 20582 (2015).
164. Mohsen, A. et al. Hepatitis C virus acquisition among Egyptians: analysis of a 10-year surveillance of acute hepatitis C. Tropical medicine & international health: TM & IH 20, 89-97, https://doi. org/10. 1111/tmi. 12410 (2015).
165. Paez Jimenez, A. et al. Injection drug use is a risk factor for HCV infection in urban Egypt. PloS one 4, e7193, https://doi. org/10. 1371/journal. pone. 0007193 (2009).
166. El-Sherif, A. et al. High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis. Hemodialysis international. International Symposium on Home Hemodialysis 16, 420-427, https://doi. org/10. 1111/j. 1542-4758. 2011. 00662. x (2012).
167. Khodir, S. A., Alghateb, M., Okasha, K. M. & Shalaby Sel, S. Prevalence of HCV infections among hemodialysis patients in Al Gharbiyah Governorate, Egypt. Arab journal of nephrology and transplantation 5, 145-147 (2012).
168. Meky, F. A. et al. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 42, 628-633, https://doi. org/10. 1086/500133 (2006).